• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

molecular diagnostics

Startup Velsera Launches to Advance Precision Health Through Data-Driven Solutions

by Fred Pennic 01/13/2023 Leave a Comment

Startup Velsera Launches to Advance Precision Health Through Data-Driven Solutions

What You Should Know:  -  New company Velsera was announced at the J.P. Morgan Healthcare Conference supported by thematic-focused impact fund Summa Equity (“Summa”). - Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world. Velsera creates a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and potential of multi-omics. - Velsera, headquartered in
Read More

Naveris Raises $51M for Early Detection of Viral-Driven Cancers

by Syed Hamza Sohail 09/21/2022 Leave a Comment

Naveris Raises $51M for Early Detection of Viral-Driven Cancers

What You Should Know: - Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M. - The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society. Using DNA Fragmentomics Technology to Detect
Read More

Femtech Startup Nanopath Raises $10M to Develop POC Diagnostics for Women’s Health

by Fred Pennic 08/10/2022 Leave a Comment

Femtech Startup Nanopath Raises $10M to Develop POC Diagnostics for Women's Health

What You Should Know: - Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes raises $10M in Series A funding, co-led by co-led by Norwest Venture Partners and Medtech Convergence Fund, to develop a point-of-care diagnostics platform for women’s health screenings. - The company plans to use the latest round of funding to support development and commercialization of Nanopath's biosensing platform that aims to transform how women's pelvic and
Read More

Healthcare & Life Science M&A Activity Plummets 1H’22

by Syed Hamza Sohail 08/05/2022 Leave a Comment

Healthcare & Life Science M&A Activity Plummets 1H’22

What You Should Know: - The index of Healthcare & Life Science equities tracked by Stout was down 16.8% in Q2 2022, which was in line with the S&P 500 decline of 16.4%. - Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. The report reveals credit markets likely to tighten, but a healthy level of M&A is expected to continue in the growing and defensive healthcare sector. Key Trends and
Read More

BillionToOne Raises $125M to Expand Genetic Testing Platform

by Jasmine Pennic 03/30/2022 Leave a Comment

BillionToOne Raises $125M to Expand Genetic Testing Platform

What You Should Know: - BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all raises $125M in Series C funding co-led by Adams Street Partners and existing investor Hummingbird Ventures with significant participation from Baillie Gifford, Neotribe Ventures, Norwest Venture Partners, Civilization Ventures, Fifty Years VC, Pacific 8 Ventures, Time BioVentures, and Libertus Capital, among others. - This
Read More

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

by Fred Pennic 05/28/2020 Leave a Comment

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San Francisco, CA-based provider of precision oncology solutions announced $30
Read More

Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force

by Jasmine Pennic 03/19/2020 Leave a Comment

Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

What You Should Know: - More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic. - The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More

Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019

by Fred Pennic 12/27/2019 Leave a Comment

Kareo Sells Managed Billing Services Business to Health Prime International

- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter. Q1 M&A Activity Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More

Pages: Page 1 Page 2 Page 3 Page 4

CareDx Acquires OTTR for $16M to Enable EMR Integrations at Transplant Centers

by Jasmine Pennic 04/29/2019 Leave a Comment

CareDx Acquires OTTR for $16M to Enable EMR Integrations at Transplant Centers

CareDx, Inc., a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients has agreed to acquire OTTR Complete Transplant Management (“OTTR”), a provider of organ transplant patient tracking software.Financial DetailsCareDx will pay approximately $16M to acquire OTTR and intends to fund the transaction with cash on hand. For the full year 2019, OTTR’s revenue is projected to be
Read More

Octave Bioscience Grabs $14M for Care Management Platform Focused on Neurodegenerative Diseases

by Fred Pennic 07/12/2018 Leave a Comment

Octave Bioscience Grabs $14M for Care Management Platform Focused on Neurodegenerative Diseases

Octave Bioscience lands $14M to bring expertise in chronic neurodegenerative markets and molecular Insights for improved care.Octave Bioscience, a Menlo Park, CA-based developer of a fully integrated care management platform delivering powerful insights for patients with neurodegenerative diseases, today announced it has raised $14 million in Series A funding. The round was led by BCBS Venture Partners with participation from Echo Health Ventures (a strategic collaboration of Cambia Health
Read More

  • Go to page 1
  • Go to page 2
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |